Tyler Calvin Downey is a pharmacist who is specialized in Oncology in Idaho Falls, Idaho. Patients can reach him at 2325 Coronado St, Idaho Falls or contact him on 208-557-2738. Active license number of Tyler Calvin Downey is P8832 for Oncology in Idaho. Tyler Calvin Downey is a licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.
Complete Profile:
Tyler Calvin Downey speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for enquiries.
Name:
Tyler Calvin Downey
Specialization:
Oncology
Credentials:
PHARMD
Gender:
Male
Location:
2325 Coronado St, Idaho Falls, Idaho, 83404-7407
Phone:
208-557-2738
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of Tyler Calvin Downey are as mentioned below.
NPI Number:
1124639174
NPI Enumeration Date:
13 Aug, 2020
NPI Last Update On:
13 Aug, 2020
Medical Licenses:
Pharmacists can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Tyler Calvin Downey are as mentioned below.
Specialization
License Number
State
Status
Oncology
P8832
Idaho
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
3580 Red Cliff Blvd # A, Idaho Falls, Idaho
Zip:
83401-1758
Phone Number:
307-256-4481
Fax Number:
--
Patients can reach Tyler Calvin Downey at 2325 Coronado St, Idaho Falls, Idaho or can call on phone at 208-557-2738.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 09 December, 2024.